Cargando…

Intratumoral morphological heterogeneity of breast cancer: neoadjuvant chemotherapy efficiency and multidrug resistance gene expression

In this study, the influence of intratumoral morphological heterogeneity of breast cancer on neoadjuvant chemotherapy (NAC) efficiency was investigated. In particular, we analysed the association of NAC response and pre- and post-NAC expression of the main multidrug resistance (MDR) genes - ABCB1, A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Denisov, Evgeny V., Litviakov, Nikolay V., Zavyalova, Marina V., Perelmuter, Vladimir M., Vtorushin, Sergey V., Tsyganov, Matvey M., Gerashchenko, Tatiana S., Garbukov, Evgeny Yu., Slonimskaya, Elena M., Cherdyntseva, Nadezhda V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988480/ https://www.ncbi.nlm.nih.gov/pubmed/24736530 http://dx.doi.org/10.1038/srep04709

Ejemplares similares

Phenotypic Drift as a Cause for Intratumoral Morphological Heterogeneity of Invasive Ductal Breast Carcinoma Not Otherwise Specified
por: Zavyalova, Marina V., et al.
Publicado: (2013)

Intratumoral Morphological Heterogeneity of Breast Cancer As an Indicator of the Metastatic Potential and Tumor Chemosensitivity
por: Gerashchenko, T.S., et al.
Publicado: (2017)

Deletions of multidrug resistance gene loci in breast cancer leads to the down-regulation of its expression and predict tumor response to neoadjuvant chemotherapy
por: Litviakov, Nikolai V., et al.
Publicado: (2016)

Markers of Cancer Cell Invasion: Are They Good Enough?
por: Gerashchenko, Tatiana S., et al.
Publicado: (2019)

Clinically relevant morphological structures in breast cancer represent transcriptionally distinct tumor cell populations with varied degrees of epithelial-mesenchymal transition and CD44(+)CD24(-) stemness
por: Denisov, Evgeny V., et al.
Publicado: (2017)

Heterogeneous Manifestations of Epithelial–Mesenchymal Plasticity of Circulating Tumor Cells in Breast Cancer Patients
por: Tashireva, Liubov A., et al.
Publicado: (2021)

Mechanisms behind prometastatic changes induced by neoadjuvant chemotherapy in the breast cancer microenvironment
por: Perelmuter, Vladimir M, et al.
Publicado: (2019)

Amplifications of Stemness Gene Loci—New Markers for the Determination of the Need for Neoadjuvant Chemotherapy for Patients with Breast Cancer. A Prospective Study
por: Litviakov, Nikolai V., et al.
Publicado: (2021)

Premalignant Changes in the Bronchial Epithelium Are Prognostic Factors of Distant Metastasis in Non-Small Cell Lung Cancer Patients
por: Pankova, Olga V., et al.
Publicado: (2021)

The Activity of KIF14, Mieap, and EZR in a New Type of the Invasive Component, Torpedo-Like Structures, Predetermines the Metastatic Potential of Breast Cancer
por: Gerashchenko, Tatiana S., et al.
Publicado: (2020)

Tumor-associated macrophages in human breast cancer produce new monocyte attracting and pro-angiogenic factor YKL-39 indicative for increased metastasis after neoadjuvant chemotherapy
por: Liu, Tengfei, et al.
Publicado: (2018)

The Novel Association of Early Apoptotic Circulating Tumor Cells with Treatment Outcomes in Breast Cancer Patients
por: Grigoryeva, Evgeniya S., et al.
Publicado: (2022)

Neoadjuvant chemotherapy combined with intraoperative radiotherapy is effective to prevent recurrence in high-risk non-small cell lung cancer (NSCLC) patients
por: Pankova, Olga V., et al.
Publicado: (2020)

Molecular subtype conversion in CTCs as indicator of treatment adequacy associated with metastasis-free survival in breast cancer
por: Grigoryeva, E. S., et al.
Publicado: (2022)

Heterogeneity of Circulating Tumor Cells in Neoadjuvant Chemotherapy of Breast Cancer
por: Kaigorodova, Evgeniya V., et al.
Publicado: (2018)

Cancer Invasion: Patterns and Mechanisms
por: Krakhmal, N. V., et al.
Publicado: (2015)

Whole Transcriptome Analysis of Breast Cancer Tumors during Neoadjuvant Chemotherapy: Association with Hematogenous Metastasis
por: Ibragimova, Marina K., et al.
Publicado: (2022)

Single Tumor Cells With Epithelial-Like Morphology Are Associated With Breast Cancer Metastasis
por: Tashireva, Liubov A., et al.
Publicado: (2020)

Amplifications of stemness genes and the capacity of breast tumors for metastasis
por: Litviakov, Nikolai, et al.
Publicado: (2020)

Amplification of Stem Genes: New Potential Metastatic Makers in Patients with an Early Form of Breast Cancer
por: Tsyganov, Matvey M., et al.
Publicado: (2019)

Determination of BRCAness Phenotype in Breast Tumors for the Appointment of Neoadjuvant Chemotherapy Based on Platinum and Taxanes
por: Tsyganov, Matvey Mihajlovich, et al.
Publicado: (2022)

DNA Copy Number Aberrations and Expression of ABC Transporter Genes in Breast Tumour: Correlation with the Effect of Neoadjuvant Chemotherapy and Prognosis of the Disease
por: Tsyganov, Matvey M., et al.
Publicado: (2022)

Predictive and Prognostic Significance of mRNA Expression and DNA Copies Aberrations of ERCC1, RRM1, TOP1, TOP2A, TUBB3, TYMS, and GSTP1 Genes in Patients with Breast Cancer
por: Tsyganov, Matvey M., et al.
Publicado: (2022)

Personalized Prescription of Chemotherapy Based on Assessment of mRNA Expression of BRCA1, RRM1, ERCC1, TOP1, TOP2α, TUBβ3, TYMS, and GSTP1 Genes in Tumors Compared to Standard Chemotherapy in the Treatment of Non-Small-Cell Lung Cancer
por: Tsyganov, Matvey M., et al.
Publicado: (2022)

Molecular-Genetic Portrait of Breast Cancer with Triple Negative Phenotype
por: Ibragimova, Marina K., et al.
Publicado: (2021)

Heterogeneity of Stemlike Circulating Tumor Cells in Invasive Breast Cancer
por: Savelieva, Olga E., et al.
Publicado: (2020)

DNA methylation markers panel can improve prediction of response to neoadjuvant chemotherapy in luminal B breast cancer
por: Sigin, Vladimir O., et al.
Publicado: (2020)

Human papillomavirus and prostate cancer: systematic review and meta-analysis
por: Tsydenova, Irina A., et al.
Publicado: (2023)

CNA Landscape of HER2-Negative Breast Cancer in Anthracycline-Based Neoadjuvant Chemotherapy Regimens
por: Ibragimova, M. K., et al.
Publicado: (2023)

Tumor-associated macrophages respond to chemotherapy by detrimental transcriptional reprogramming and suppressing stabilin-1 mediated clearance of EGF
por: Larionova, Irina, et al.
Publicado: (2023)

Tumour Stem Cells in Breast Cancer
por: Ibragimova, Marina, et al.
Publicado: (2022)

Organ-Specificity of Breast Cancer Metastasis
por: Ibragimova, Marina K., et al.
Publicado: (2023)

Measuring Intratumoral Heterogeneity of Immune Repertoires
por: Yuzhakova, Diana Vladimirovna, et al.
Publicado: (2020)

Cortical branched actin determines cell cycle progression
por: Molinie, Nicolas, et al.
Publicado: (2019)

Spatial Profile of Tumor Microenvironment in PD-L1-Negative and PD-L1-Positive Triple-Negative Breast Cancer
por: Tashireva, Liubov A., et al.
Publicado: (2023)

DNA Methylation and Prospects for Predicting the Therapeutic Effect of Neoadjuvant Chemotherapy for Triple-Negative and Luminal B Breast Cancer
por: Sigin, Vladimir O., et al.
Publicado: (2023)

Effect of Targeted Therapy With Pazopanib on Expression Levels of Transcription, Growth Factors and Components of AKT/m-TOR Signaling Pathway in Patients with Renal Cell Carcinoma
por: Spirina, Liudmila V, et al.
Publicado: (2017)

Plasma miR-19b and miR-183 as Potential Biomarkers of Lung Cancer
por: Zaporozhchenko, Ivan A., et al.
Publicado: (2016)

Profiling of 179 miRNA Expression in Blood Plasma of Lung Cancer Patients and Cancer-Free Individuals
por: Zaporozhchenko, Ivan A., et al.
Publicado: (2018)

Comparison of the Illumina NextSeq 2000 and GeneMind Genolab M sequencing platforms for spatial transcriptomics
por: Pavel, Iamshchikov, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t921k6epnu26hhjl28g4e72mtc